Wednesday, February 10, 2010, 2:26PM AEST - The Australian Stockmarket closes in 1 hour and 39 minutes.
To create a watchlist or portfolio of shares, Register

Kendle International Inc. (KNDL)

8:00AM AEST: 19.46 USD  Up 0.37 (1.94%)  
 MORE ON KNDL 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Kendle International Inc. (NasdaqNM:KNDL) Delayed quote dataEdit
Last Trade:19.46 USD
Trade Time: 8:00AM AEST
Change:Up 0.37 (1.94%)
Prev Close:19.09
Open:18.93
Bid:18.91 x 200
Ask:20.01 x 200
1y Target Est:13.50
Day's Range:18.93 - 19.65
52wk Range:8.28 - 23.54
Volume:67,019
Avg Vol (3m):168,775
Market Cap:289.58M
P/E (ttm):12.96
EPS (ttm):1.50
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add KNDL to Portfolio   Download Data

 HEADLINES 
5-Star Stocks on the Upswing
at Motley Fool (Fri, Jan 22)
Contract Researchers, PBMs Eye Strong 2010
Investor's Business Daily (Fri, Jan 1)
We Expect Ailing CROs to Recover
Morningstar.com (Wed, Nov 25)
KENDLE INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi
EDGAR Online (Tue, Nov 17)
KENDLE INTERNATIONAL INC Financials
EDGAR Online Financials (Sat, Nov 14)
KENDLE INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
KENDLE INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Nov 5)
KENDLE INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rig
EDGAR Online (Thu, Aug 20)
KENDLE INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Aug 6)
KENDLE INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
EDGAR Online (Wed, Jul 29)
More Headlines for KNDL...

 ANALYST 
EPS Est (next year) (Dec-09) :1.89
EPS Est (in 2 years) (Dec-10) :1.49
Avg Rec (current)*:3.3
PEG Ratio:0.76
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Kendle International Inc., a clinical research organization, provides clinical development services on a contract basis to the biopharmaceutical industry worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices